Skip to main content

Table 2 Postoperative adverse events of thyroid surgery [25, 58]

From: Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience

Postoperative adverse event

Frequency (%)

All risk PTC patients

n: 14,934

Low-risk PTC patients

n: 135

Total Thyroidectomy

Lobectomy

Total Thyroidectomy

Lobectomy

Total adverse events

N/A

n = 33 (24.4%)

Permanent adverse events

 

n = 13 (9.6%)

Hypoparathyroidism

10%

17%

 Transient

14%

0,4%

9.7%

0%

 Permanent

2,2%

0,07%

5.2%

 Partiala

  

2.2%

 Parathyroid in surgical piece (without Hipoparathyroidism)

  

3.8%

Vocal cord paralysis

3.4%

3%

 Transient

2,4%

1,4%

0.7%

0%

 Permanent

1,3%

0,6%

2.2%

 Bilateral

0,6%

0%

0.7%

Hypothyroidism

N/A

100%

50%

Hematoma

1,6%

0,4%

1,5%

0%

Surgical wound infection

0,4%

0,13%

0,7%

0%

Keloid scar

N/A

2,2%

0%

External superior laryngeal nerve injury

0,4%

N/A

Thoracic duct injury

0,2%

Ulnar nerve injury

0,2%

Otherb

0,9%

  1. a Defined as a clinical disorder with normal serum parathormone but a requirement for ongoing calcium and calcitriol supplementation in order to avoid hypocalcemia and its symptoms for more than 6 months
  2. b Other complications: Claude-Bernard-Horner syndrome, punctate keratitis, alterations caused by neck hyperextension during surgery: vertigo, headache, nausea